Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Ovarian Neoplasms

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 64 articles: HTML format Text format

Single Articles

January 2012
1. WHITE KL , Schildkraut JM, Palmieri RT, Iversen ES, et al
   Ovarian Cancer Risk Associated with Inherited Inflammation-Related Variants.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. ARORA HC , Jensen MP, Yuan Y, Wu A, et al
   Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. KULBE H , Chakravarty P, Leinster DA, Charles KA, et al
   A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
4. OBERMAJER N , Muthuswamy R, Odunsi KO, Edwards R, et al
   PGE2-Dependent CXCL12 Production and CXCR4 Expression Control the Accumulation of Human MDSCs in Ovarian Cancer Environment.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SOMMARIVA M , De Cecco L, De Cesare M, Sfondrini L, et al
   TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.
   Cancer Res. 2011;71:6382-90.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
6. GUAN B , Wang TL, Shih IM
   ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. STEFANSKA B , Huang J, Bhattacharyya B, Suderman M, et al
   Definition of the landscape of promoter DNA hypomethylation in liver cancer.
   Cancer Res. 2011;71:5891-903.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
8. BITLER BG , Nicodemus JP, Li H, Cai Q, et al
   Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. HUBERT P , Heitzmann A, Viel S, Nicolas A, et al
   Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy.
   Cancer Res. 2011;71:5134-43.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. SWAMINATHAN V , Mythreye K, O'Brien ET, Berchuck A, et al
    Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines.
    Cancer Res. 2011;71:5075-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
11. REBBECK TR , Mitra N, Domchek SM, Wan F, et al
    Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1 Interacting Genes.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. DARSHAN MS , Loftus MS, Thadani-Mulero M, Levy BP, et al
    Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. HU W , Lu C, Han HD, Huang J, et al
    Biological roles of the Delta family notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. FUCIKOVA J , Kralikova P, Fialova A, Brtnicky T, et al
    Human tumor cells killed by anthracyclines induce a tumor-specific immune response.
    Cancer Res. 2011;71:4821-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. RIGHI E , Kashiwagi S, Yuan J, Santosuosso M, et al
    CXCL12/CXCR4 blockade induces multimodal anti-tumor effects and prolongs survival of immunocompetent mice with ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. POLYTARCHOU C , Iliopoulos D, Hatziapostolou M, Kottakis F, et al
    Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation.
    Cancer Res. 2011;71:4720-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SONG DG , Ye Q, Carpenito C, Poussin M, et al
    In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).
    Cancer Res. 2011;71:4617-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
18. LABIDI-GALY SI , Sisirak V, Meeus P, Gobert M, et al
    Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. KONSTANTINOPOULOS PA , Spentzos D, Fountzilas E, Francoeur N, et al
    Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
20. HUEHLS AM , Wagner JM, Huntoon CJ, Geng L, et al
    Poly(ADP-ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. STRONACH EA , Alfraidi AM, Rama NR, Datler C, et al
    HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
22. SILVA IA , Bai S, McLean K, Yang K, et al
    Aldehyde dehydrogenase and CD133 define angiogenic ovarian cancer stem cells that portend poor patient survival.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. PERMUTH-WEY J , Kim D, Tsai YY, Lin HY, et al
    LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. URICK ME , Rudd ML, Godwin AK, Sgroi DC, et al
    PIK3R1 (p85-alpha/p85{alpha}) is Somatically Mutated at High Frequency in Primary Endometrial Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
25. RUDNICK SI , Lou J, Shaller CC, Tang Y, et al
    Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors.
    Cancer Res. 2011;71:2250-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. SYED N , Coley HM, Sehouli J, Koensgen D, et al
    Polo-like kinase PLK 2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
27. WU J , Liu Z, Shao C, Gong Y, et al
    HMGA2 Overexpression-Induced Ovarian Surface Epithelial Transformation Is Mediated Through Regulation of EMT Genes.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
28. JAIN HV , Meyer-Hermann M
    The Molecular Basis of Synergism between Carboplatin and ABT-737 Therapy Targeting Ovarian Carcinomas.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. LO CW , Chen MW, Hsiao M, Wang S, et al
    IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
30. CHEN H , Wu X, Pan ZK, Huang S, et al
    Integrity of SOS1/EPS8/ABI1 Tri-Complex Determines Ovarian Cancer Metastasis.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. LIANG D , Meyer L, Chang DW, Lin J, et al
    Genetic Variants in MicroRNA Biosynthesis Pathways and Binding Sites Modify Ovarian Cancer Risk, Survival, and Treatment Response.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. WYNENDAELE J , Bohnke A, Leucci E, Nielsen SJ, et al
    An Illegitimate microRNA Target Site within the 3' UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. RIZVI I , Celli JP, Evans CL, Abu-Yousif AO, et al
    Synergistic Enhancement of Carboplatin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Ovarian Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. TAN Y , Cheung M, Pei J, Menges CW, et al
    Upregulation of DLX5 Promotes Ovarian Cancer Cell Proliferation by Enhancing IRS-2-AKT Signaling.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. RAHMANZADEH R , Rai P, Celli JP, Rizvi I, et al
    Ki-67 as a Molecular Target for Therapy in an In vitro Three-Dimensional Model for Ovarian Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. HUNTOON CJ , Nye MD, Geng L, Peterson KL, et al
    Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
    Cancer Res. 2010;70:8642-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
37. SPILLMAN MA , Manning NG, Dye WW, Sartorius CA, et al
    Tissue-Specific Pathways for Estrogen Regulation of Ovarian Cancer Growth and Metastasis.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. WINER I , Wang S, Lee YE, Fan W, et al
    F3-Targeted Cisplatin-Hydrogel Nanoparticles as an Effective Therapeutic that Targets Both Murine and Human Ovarian Tumor Endothelial Cells In vivo.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. HALL CA , Wang R, Miao J, Oliva E, et al
    The Hippo Pathway Effector, Yap, is an Ovarian Cancer Oncogene.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. CHOCK KL , Allison JM, Shimizu Y, Elshamy WM, et al
    BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. WHITEHURST AW , Xie Y, Purinton SC, Cappell KM, et al
    Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation.
    Cancer Res. 2010;70:7652-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
42. RANKIN EB , Fuh KC, Taylor TE, Krieg AJ, et al
    AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
43. IBRAHIM N , He L, Leong CO, Xing D, et al
    BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
44. RATNER E , Lu L, Boeke M, Barnett R, et al
    A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
45. RASPAGLIO G , De Maria I, Filippetti F, Martinelli E, et al
    HuR Regulates {beta}-Tubulin Isotype Expression in Ovarian Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. AGARWAL A , Tressel SL, Kaimal R, Balla M, et al
    Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. KUBLER K , Gehrke N, Riemann S, Bohnert V, et al
    Targeted Activation of RNA Helicase Retinoic Acid-Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SU JL , Chen PB, Chen YH, Chen SC, et al
    Downregulation of microRNA miR-520h by E1A contributes to anticancer activity.
    Cancer Res. 2010;70:5096-108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. BAPAT SA , Krishnan A, Ghanate AD, Kusumbe AP, et al
    Gene Expression: Protein Interaction Systems Network Modeling Identifies Transformation-Associated Molecules and Pathways in Ovarian Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. JIANG T , Chen N, Zhao F, Wang XJ, et al
    High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
51. MOUCHAWAR J , Korch C, Byers T, Pitts TM, et al
    Population-Based Estimate of the Contribution of TP53 Mutations to Subgroups of Early-Onset Breast Cancer: Australian Breast Cancer Family Study.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. REIMER D , Hubalek M, Riedle S, Skvortsov S, et al
    E2F3a Is Critically Involved in Epidermal Growth Factor Receptor-Directed Proliferation in Ovarian Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. TANAKA T , Mangala LS, Vivas-Mejia PE, Nieves-Alicea R, et al
    Sustained small interfering RNA delivery by mesoporous silicon particles.
    Cancer Res. 2010;70:3687-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
54. HERNANDEZ L , Hsu SC, Davidson B, Birrer MJ, et al
    Activation of NF-{kappa}B Signaling by Inhibitor of NF-{kappa}B Kinase {beta} Increases Aggressiveness of Ovarian Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. HE X , Ota T, Liu P, Su C, et al
    Downregulation of HtrA1 Promotes Resistance to Anoikis and Peritoneal Dissemination of Ovarian Cancer Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
56. DONG Y , Tan OL, Loessner D, Stephens C, et al
    Kallikrein-Related Peptidase 7 Promotes Multicellular Aggregation via the {alpha}5{beta}1 Integrin Pathway and Paclitaxel Chemoresistance in Serous Epithelial Ovarian Carcinoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. JIN D , Fan J, Wang L, Thompson LF, et al
    CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
    Cancer Res. 2010;70:2245-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. WOLTERINK S , Moldenhauer G, Fogel M, Kiefel H, et al
    Therapeutic Antibodies to Human L1CAM: Functional Characterization and Application in a Mouse Model for Ovarian Carcinoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
59. IORIO E , Ricci A, Bagnoli M, Pisanu ME, et al
    Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. CREIGHTON CJ , Fountain MD, Yu Z, Nagaraja AK, et al
    Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. WANDALL HH , Blixt O, Tarp MA, Pedersen JW, et al
    Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.
    Cancer Res. 2010;70:1306-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. TARALLO V , Vesci L, Capasso O, Esposito MT, et al
    A Placental Growth Factor Variant Unable to Recognize Vascular Endothelial Growth Factor (VEGF) Receptor-1 Inhibits VEGF-Dependent Tumor Angiogenesis via Heterodimerization.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
63. YAN X , Yin J, Yao H, Mao N, et al
    Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. GALANIS E , Hartmann LC, Cliby WA, Long HJ, et al
    Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: